Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann
(1.21)
# 4,466
Out of 5,182 analysts
18
Total ratings
40%
Success rate
-3.9%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Maintains: Buy | $64 → $66 | $38.23 | +72.64% | 2 | Nov 12, 2025 | |
| CELH Celsius Holdings | Maintains: Neutral | $62 → $58 | $32.29 | +79.62% | 3 | Mar 27, 2025 | |
| ECOR electroCore | Maintains: Buy | $28 → $26 | $6.40 | +306.25% | 2 | Mar 13, 2025 | |
| NUWE Nuwellis | Downgrades: Neutral | n/a | $1.09 | - | 1 | Nov 8, 2023 | |
| SABS SAB Biotherapeutics | Downgrades: Neutral | n/a | $4.11 | - | 1 | Oct 5, 2023 | |
| FBIO Fortress Biotech | Initiates: Buy | $90 | $2.39 | +3,665.69% | 1 | Aug 4, 2022 | |
| OPK OPKO Health | Initiates: Buy | $7 | $1.14 | +514.04% | 1 | Jun 21, 2021 | |
| NNOX Nano-X Imaging | Initiates: Buy | $52 | $1.73 | +2,905.78% | 1 | Apr 19, 2021 | |
| TENX Tenax Therapeutics | Upgrades: Buy | n/a | $11.66 | - | 1 | May 18, 2017 | |
| CNMD CONMED | Downgrades: Neutral | n/a | $36.76 | - | 5 | Apr 27, 2017 |
Harrow
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $66
Current: $38.23
Upside: +72.64%
Celsius Holdings
Mar 27, 2025
Maintains: Neutral
Price Target: $62 → $58
Current: $32.29
Upside: +79.62%
electroCore
Mar 13, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $6.40
Upside: +306.25%
Nuwellis
Nov 8, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.09
Upside: -
SAB Biotherapeutics
Oct 5, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.11
Upside: -
Fortress Biotech
Aug 4, 2022
Initiates: Buy
Price Target: $90
Current: $2.39
Upside: +3,665.69%
OPKO Health
Jun 21, 2021
Initiates: Buy
Price Target: $7
Current: $1.14
Upside: +514.04%
Nano-X Imaging
Apr 19, 2021
Initiates: Buy
Price Target: $52
Current: $1.73
Upside: +2,905.78%
Tenax Therapeutics
May 18, 2017
Upgrades: Buy
Price Target: n/a
Current: $11.66
Upside: -
CONMED
Apr 27, 2017
Downgrades: Neutral
Price Target: n/a
Current: $36.76
Upside: -